RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Evansville, IN · Indianapolis, IN · New Albany, IN · +119 more sites
Psoriasis clinical trials in Indianapolis, IN
7 recruiting psoriasis studies with a site in Indianapolis, IN.
RecruitingPhase 3NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Sponsor: Janssen Research & Development, LLC
Indianapolis, IN · +5 more sites
RecruitingPhase 3NCT07362017
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Sponsor: Vanda Pharmaceuticals
Indianapolis, IN · +9 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Indianapolis, IN · Plainfield, IN · +37 more sites
RecruitingPhase 3NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Indianapolis, IN · +46 more sites
RecruitingPhase 3NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Sponsor: AbbVie
Indianapolis, IN · +11 more sites
RecruitingPhase not listedNCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sponsor: Duke University
Indianapolis, IN · +74 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.